Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.490
-0.100 (-3.86%)
At close: Sep 16, 2026, 4:00 PM EDT
2.490
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Virax Biolabs Group Employees
Virax Biolabs Group had 26 employees as of March 31, 2026. The number of employees increased by 7 or 36.84% compared to the previous year.
Employees
26
Change (1Y)
7
Growth (1Y)
36.84%
Revenue / Employee
$478
Profits / Employee
-$193,221
Market Cap
1.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 26 | 7 | 36.84% |
| Mar 31, 2025 | 19 | 2 | 11.76% |
| Mar 31, 2024 | 17 | 6 | 54.55% |
| Mar 31, 2023 | 11 | 6 | 120.00% |
| Mar 31, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Curis | 24 |
| Tessera Defense and Homeland Security | 20 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| Oragenics | 3 |
| Propanc Biopharma | 2 |
VRAX News
- 7 weeks ago - Virax Biolabs files to sell 1.68M ordinary shares for holders - TheFly
- 2 months ago - Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement - PRNewsWire
- 2 months ago - Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - PRNewsWire
- 2 months ago - Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - PRNewsWire
- 2 months ago - Why this biotech stock more than tripled on Thursday - Invezz
- 2 months ago - Why Is Penny Stock Virax Biolabs (VRAX) Up Today? - TipRanks
- 2 months ago - Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics - TheFly
- 2 months ago - Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics - PRNewsWire